Le Lézard
Classified in: Health
Subject: SVY

Outpatient Clinics Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2022)


NEW YORK, Feb. 14, 2018 /PRNewswire/ -- The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries.



Read the full report: https://www.reportlinker.com/p05328064



Management of high-risk situations has led to increasing number of outpatient clinics globally. Therapists in the outpatient clinics are adopting measures to prevent and identify the cognitive behavioral disorders. Growing need for relapse prevention and management is expected to contribute towards growth of the global outpatient clinics market during the forecast period.

According to Future Market Insights, the global outpatient clinics market is expected to represent a value of over US$ 39,000 Mn by the end of 2022.

Alcohol and Drug Addiction to Fuel Demand
With more number of people in grip of alcohol addiction and drugs, the need for rehab centers continue to increase. Outpatient rehabs allows the patient to live at home during the alcohol or drug rehabilitation program.

In addition, treatment at the outpatient rehabs is comparatively cheaper than the inpatient and residential treatments. With the growing need for treatment of alcohol addiction problem, demand for outpatient clinics is expected to increase in the global market.

Healthcare Insurance to Impact Market Growth
Maintenance of employee health is increasingly becoming important to keep them working.

Organizations are increasingly offering their employees' health insurance benefits in order to ensure that good health of the employees while working. Provision of health insurance to the employees is further expected to impact growth of the global market during the forecast period.

In addition, regulations such as Patient Care Affordable Act and the Health Care and Educational Reconciliation Act has further established exchanges that offer access to the private health insurance and provides the citizens of America with public health coverage. A recent trend witnessed among the private insurance companies is that they are focusing on negotiating with the outpatient clinics for enhanced payment and services offered.

Technological Advancements to Underscore Significant Opportunities
Advanced medical technology has also led to therapies and drugs that have enabled the procedures, medical tests and therapies without the need for lengthy stays in the night. Prevalence of chronic diseases will continue to rev up demand for immediate treatment and services.

Demand for the outpatient clinic services will continue to gain momentum bound to growing need for immediate treatment and convenience to the healthcare providers and patients. Benefits such as cheaper establishment and the operational costs of the outpatient clinics is further expected to propel growth of global outpatient clinic market.

On the other hand, stringent regulatory framework and lack of doctors to treat the patients continues to remain a major factor inhibiting growth of the global market. In addition, development of the healthcare sector in various developing countries is further likely to impact demand for the outpatient clinics negatively.

As the outpatient clinics do not admit the patients, the risks of getting addicted again and being exposed to drugs or alcohol continues to remain high. Access to the counselor is expected to remain limited as compared to the inpatient and residential facility.

Multi-Specialty Centers to Represent a Leading Segment
With the growing need for various treatments, demand for multi-specialty center will continue to increase.

On the basis of center type, the multi-specialty center segment is expected to generate significant revenues, accounting for a value of over US$ 8,400 Mn by the end of 2022. The multi-specialty center segment is expected to register the highest CAGR throughout the forecast period.

Based on specialty type, the cardiology segment is expected to witness significant revenue growth, recording a value of over US$ 3,000 Mn by the end of 2022. The dermatology specialty areas segment is expected to register a robust CAGR during the forecast period.

Competition Tracking
Leading market players operating in the global outpatient clinics market include M D Anderson Cancer Center, Kaiser Permanente Inc., Memorial Sloan Kettering, Mayo Clinic, DaVita Inc., University of Maryland Medical Center, Johns Hopkins Medicine, Cleveland Clinic and Fresenius Medical Care.

Read the full report: https://www.reportlinker.com/p05328064

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]  
US: (339)-368-6001
Intl: +1 339-368-6001 

SOURCE Reportlinker


These press releases may also interest you

at 15:26
An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set to enhance the...

at 15:12
The Canadian Life and Health Insurance Association (CLHIA) supports the steps announced by the Ontario government yesterday to help family doctors and other primary care providers spend more time with their patients and less time on paperwork. "Our...

at 15:05
On May 26, Dawnmarie Gaivin and Dana Johnson, founders of the Spellers Methodtm used by thousands of nonspeaking individuals with autism, in partnership with filmmaker Pat R. Notaro III, will launch a video-on-demand docuseries that chronicles what...

at 14:53
Erie Insurance (ERIE) has received the 2024 Best Employers: Excellence in Health & Well-being award from Business Group on Health. The annual corporate awards program recognizes companies across diverse sectors for advancing employee well-being...

at 14:41
Cartessa Aesthetics, a premier North American aesthetic medical device company, launches PHYSIQ 360, a groundbreaking technology that elevates non-invasive body contouring. PHYSIQ 360 is the next generation of the award-winning PHYSIQ body technology...

at 14:37
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of...



News published on and distributed by: